Heidi A. Dare
Shareholder
Heidi counsels clients in patent related matters including international patent portfolio management and due diligence analyses. Heidi’s practice focuses on patent prosecution in technical areas of molecular biology, medical device and medical diagnostics. Heidi’s prosecution experience includes preparing and prosecuting applications in technologies including RNA interference, recombinant nucleic acid and protein technologies, mutational analysis, antibody therapies, transgenic animals and plants, therapeutic vectors, stem cell therapies, and gene therapy. 

Heidi counsels a diverse group of clients from corporate clients of all sizes, university clients and start-ups. Heidi has prosecuted over 1000 patent applications in the U.S. and worldwide.

Prior to joining the firm in 2002, Heidi’s non-legal experience included research positions at Howard Hughes Medical Institute, University of Michigan and the Ohio State University.

Education
  • J.D.,
    Wayne State University Law School, 2002
  • M.S.,, Microbiology & Immunology
    University of Michigan, 1988
  • B.A.,, Biology
    Albion College, 1985
Bar Admissions
  • Illinois
  • U.S. Patent & Trademark Office
Technical Background
  • Biopharma
Experience | Legal

Brinks Gilson & Lione, Chicago, Illinois
Shareholder, January 2011-Present
Associate, September 2002-December 2010 

Brooks & Kushman, P.C., Southfield, Michigan
Law Clerk, May 2001-April 2002
Supported ongoing patent prosecution and litigation, including provisional applications and trademark litigation

University of Michigan, Office of the General Counsel, Ann Arbor, Michigan
Law Clerk, 2000-2001
Researched issues for all areas of law, including patent law, copyrights, contracts, UCITA, Title IX, civil rights and property

Forward Thinking
Representative Matters
Authored Patents
  • U.S. 7,456,015: Tetracycline-Regulated Adeno-Associated Viral (AAV) Vectors for Gene Delivery to the Nervous System
  • E.P. 1,799,826 B1: siRNA-Mediated Silencing of a-Synuclein

Authored Published Patent Applications

  • U.S. 2006/0118189: Flow Variation Valve Assembly
  • U.S. 2007/0172462: siRNA-Mediated Gene Silencing of Synuclein
  • U.S. 2007/0178071: Stem-Cell, Precursor Cell, or Target Cell-Based Treatment of Multiorgan Failure and Renal Dysfunction
  • U.S. 2008/0027413: Blood Products from Mesenchymal Stem Cells
  • U.S. 2008/0051721: Loop Tip Wire Guide
  • U.S. 2008/0241112: Therapy of Kidney Diseases and Multiorgan Failure with Mesenchymal Stem Cells and Mesenchymal Stem Cell Conditioned Media
  • U.S. 2008/0306465: Adjustable Length Catheter
Press Releases & Events
June 06, 2017

CHICAGO—Intellectual property law firm Brinks Gilson & Lione has been recognized for the ninth year in a row as a top U.S. firm for patent prosecution, including for re-examination and post-grant proceedings, by The Legal 500 United States 2017...

October 23, 2014
CHICAGO—Gary M. Ropski, a shareholder at intellectual property law firm Brinks Gilson & Lione and the firm's past president, has been named the #1 Leading Intellectual Property Lawyer in Illinois by Leading Lawyers, and fifty-nine ...
September 18, 2012
CHICAGO – Leading Lawyers Network has named 54 attorneys from Brinks Gilson & Lione, one of the largest intellectual property law firms in the United States, as 2012 Leading Lawyers in intellectual property in Illinois for 2012. The roster ...
Honors
  • Recommended Lawyer, Legal 500, 2017
  • Leading Intellectual Property Lawyer, Leading Lawyers Network, 2012-2016
Affiliations
  • American Bar Association
  • Illinois Biotechnology Industry Organization (iBIO)